Home
ACON
ACON News

Latest Aclarion Inc. (ACON) News on December 19, 2024

Aclarion (ACON) Upgraded to Buy: Here's What You Should Know

Zacks

13 hours ago

Aclarion (ACON) Upgraded to Buy: Here's What You Should Know

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

ACCESSWIRE

15 days ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

GlobeNewswire

a month ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

ACCESSWIRE

a month ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

GlobeNewswire

2 months ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

3 months ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

MT Newswires

3 months ago

Aclarion Establishes $10 Million At-The-Market Offering Program

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

GlobeNewswire

3 months ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

GlobeNewswire

3 months ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

ACCESSWIRE

3 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

GlobeNewswire

3 months ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Aclarion Added to PRISM Emerging Medical Devices Index

GlobeNewswire

3 months ago

Aclarion Added to PRISM Emerging Medical Devices Index

GlobeNewswire

3 months ago

Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market

GlobeNewswire

4 months ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

GlobeNewswire

4 months ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans

Aclarion Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

4 months ago

Aclarion Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GlobeNewswire

4 months ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

GlobeNewswire

4 months ago

Aclarion Announces First Commercial Agreement in Michigan

GlobeNewswire

4 months ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

GlobeNewswire

5 months ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

GlobeNewswire

6 months ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

GlobeNewswire

6 months ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution

NewMediaWire

6 months ago

Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution

Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution

NewMediaWire

6 months ago

Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution

ACCESSWIRE

8 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

NewMediaWire

8 months ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

NewMediaWire

8 months ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

GlobeNewswire

10 months ago

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

Aclarion Announces Closing of $3.0 Million Public Offering

NewMediaWire

10 months ago

Aclarion Announces Closing of $3.0 Million Public Offering

Aclarion Announces Pricing of $3.0 Million Public Offering

NewMediaWire

10 months ago

Aclarion Announces Pricing of $3.0 Million Public Offering

GlobeNewswire

10 months ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

a year ago

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

GlobeNewswire

a year ago

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?

PR Newswire

a year ago

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?

Interactive Strength, Inc. is Expanding its Presence in the Fast-growing Golf Performance Market as a New Exhibitor at the 2024 PGA Show

NewMediaWire

a year ago

Interactive Strength, Inc. is Expanding its Presence in the Fast-growing Golf Performance Market as a New Exhibitor at the 2024 PGA Show

GlobeNewswire

a year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

NewMediaWire

a year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

NewMediaWire

a year ago

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

SEC Charges Future FinTech Group CEO Huang With Manipulative Trading

The Wall Street Journal

a year ago

SEC Charges Future FinTech Group CEO Huang With Manipulative Trading

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case

GlobeNewswire

a year ago

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

NewMediaWire

a year ago

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

GeoVax Announces Issuance of Malaria Vaccine Patent

GlobeNewswire

a year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

Generation Income Properties Announces Continued Monthly Cash Distributions

ACCESSWIRE

a year ago

Generation Income Properties Announces Continued Monthly Cash Distributions

GlobeNewswire

a year ago

Aclarion Announces Reverse Stock Split

Seelos Therapeutics, Inc. Releases Letter to its Stockholders

PR Newswire

a year ago

Seelos Therapeutics, Inc. Releases Letter to its Stockholders

11 Most Promising Psychedelic Stocks According to Hedge Funds

Insider Monkey

a year ago

11 Most Promising Psychedelic Stocks According to Hedge Funds

ENGlobal Regains Compliance with Nasdaq Minimum Bid Price Requirement

ACCESSWIRE

a year ago

ENGlobal Regains Compliance with Nasdaq Minimum Bid Price Requirement

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

GlobeNewswire

a year ago

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

Optimistic Investors Push Koss Corporation (NASDAQ:KOSS) Shares Up 32% But Growth Is Lacking

Simply Wall St.

a year ago

Optimistic Investors Push Koss Corporation (NASDAQ:KOSS) Shares Up 32% But Growth Is Lacking

Janover to Ring NASDAQ Closing Bell Today

GlobeNewswire

a year ago

Janover to Ring NASDAQ Closing Bell Today

HUB Wins €15 Million Project with a Prominent Swiss Aviation Vendor

GlobeNewswire

a year ago

HUB Wins €15 Million Project with a Prominent Swiss Aviation Vendor

NextPlay Technologies Receives Notice from Nasdaq

GlobeNewswire

a year ago

NextPlay Technologies Receives Notice from Nasdaq

Snail Games Unleashes ARK: Survival Ascended on PlayStation®5 - Cross-Platform Gameplay and 250+ Mods Await

GlobeNewswire

a year ago

Snail Games Unleashes ARK: Survival Ascended on PlayStation®5 - Cross-Platform Gameplay and 250+ Mods Await

GlobeNewswire

a year ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

3 Electric Boat Stocks That Will Sail Higher by 2024

InvestorPlace

a year ago

3 Electric Boat Stocks That Will Sail Higher by 2024

GlobeNewswire

a year ago

Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds

Can-Fite: Complete Response and 6.9 Years Overall Survival in a Patient with Advanced Liver Cancer Treated with Namodenoson

Business Wire

a year ago

Can-Fite: Complete Response and 6.9 Years Overall Survival in a Patient with Advanced Liver Cancer Treated with Namodenoson

BT Brands Reports Third Quarter 2023 Results

Business Wire

a year ago

BT Brands Reports Third Quarter 2023 Results

180 Degree Capital Corp. (NASDAQ:TURN) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

180 Degree Capital Corp. (NASDAQ:TURN) Q3 2023 Earnings Call Transcript

Complete Solaria Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Complete Solaria Reports Third Quarter 2023 Results

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Creative Realities illuminates Airport Shopping with Engaging LED Experiences

GlobeNewswire

a year ago

Creative Realities illuminates Airport Shopping with Engaging LED Experiences

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Grove Collaborative Sees Record 3Q Net Revenue Per Order, Raises Guidance

Exec Edge

a year ago

Grove Collaborative Sees Record 3Q Net Revenue Per Order, Raises Guidance

Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

GlobeNewswire

a year ago

Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

GlobeNewswire

a year ago

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

Precision Optics Corporation Schedules First Quarter of Fiscal Year 2024 Conference Call for Tuesday, November 14, 2023

PR Newswire

a year ago

Precision Optics Corporation Schedules First Quarter of Fiscal Year 2024 Conference Call for Tuesday, November 14, 2023

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

GlobeNewswire

a year ago

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

Associated Press Finance

a year ago

Curo Group: Q3 Earnings Snapshot

Share on Social Networks: